Related Experiment Videos

Molecular failure of apoptosis: inappropriate cell survival and mutagenesis?

G T Williams1, M R Critchlow, V L Hedge

  • 1Biological Sciences, Keele University, Staffordshire, UK. g.t.williams@keele.ac.uk

Toxicology Letters
|February 18, 1999
PubMed

Insights

Cells may survive inappropriately due to apoptosis pathway defects. Inhibiting caspases, key apoptosis enzymes, can cause Jurkat T-cells to survive Fas-mediated apoptosis, confirming predictions.

Area of Science:

  • Cell biology
  • Molecular biology
  • Immunology

Background:

  • Apoptosis, or programmed cell death, is crucial for development and tissue homeostasis.
  • Dysregulation of apoptosis can lead to diseases like cancer and autoimmune disorders.
  • The bcl-2 family proteins are key regulators of apoptosis, and their overexpression can inhibit cell death.

Purpose of the Study:

  • To investigate the role of caspases in regulating apoptosis.
  • To determine if inhibiting caspases leads to inappropriate cell survival.
  • To analyze whether caspase inhibition affects cells before they are committed to die.

Main Methods:

  • Utilized Jurkat human T-cells for experiments.
  • Induced apoptosis using Fas-mediated stimulation.
  • Administered agents to inhibit specific caspases.
  • Assessed cell survival and apoptosis markers.

Main Results:

  • Inhibition of certain caspases resulted in the survival of Jurkat T-cells.
  • This survival occurred in cells stimulated to undergo Fas-mediated apoptosis.
  • Findings support the hypothesis that caspase inhibition can lead to inappropriate cell survival.

Conclusions:

  • Caspase inhibition can prevent programmed cell death.
  • This prevention of apoptosis by caspases can lead to inappropriate cell survival.
  • Targeting caspases may have implications for diseases involving aberrant cell death.

Related Concept Videos